Author Guide

Please take your time to consult the following instructions to help you prepare your manuscript in the Journal of Turkish Sleep Medicine, and feel free to contact us with any questions. To ensure fast peer review and publication, manuscripts that do not follow the instructions are returned to the corresponding author for technical revision before undergoing peer review.

Contents

1. About the Journal

2. Editorial Review and Acceptance

3. Manuscript Categories

4. Submission of Manuscript

5. Structure of Manuscript

6. Style of Manuscript

7. Proofs

8. Ethical Considerations

9. Clinical Trials Registry

10. Copyright

11. Tracking Manuscript

12. Early View

13. The Journal Online

1. About The Journal

Scope Journal of Turkish Sleep Medicine is the official Turkish and English language journal of the Turkish Sleep Medicine Society (TSMS), and publishes original research articles, articles, case reports and review articles on basic clinical and sociological issues, dealing with Journal of sleep medicine. Both members and non-members of the TSMS are welcome to submit papers to the journal.

The journal does not charge any article submission or processing charges.

Frequency: Four issues per year (issues in march, june, september and congress special issue in december)

E-ISSN: 2757-850X

Journal abbreviation: J Turk Sleep Med

Publisher: Galenos Yayınevi

2. Editorial Review and Acceptance

→ Review process: A submitted paper is assigned to one of the associate editors according to the topics of paper. The responsible associate editor appoints more than two reviewers for evaluating the paper and decides whether the paper should be accepted for publication, revised or rejected, according to the reviewers’ comments within four to six weeks.

→ Acceptance: The acceptance criteria for all papers are the quality and originality of the research and its significance to our readership. All manuscripts are peer reviewed. The Editor reserves the right to refuse any material for publication. Final acceptance or rejection rests with the Editorial Board.

→ Before publication: All manuscripts should be written in a clear, concise, direct style so that they are intelligible to the professional reader who is not a specialist in the particular field. Where contributions are judged as acceptable for publication on the basis of content, the Editor reserves the right to modify manuscripts to eliminate ambiguity and repetition and improve communication between author and reader. If extensive alterations are required, the manuscript will be returned to the author for revision. Starting from 2025, the language of publication will be English, but all articles will continue to have English and Turkish abstracts. Authors will be asked to submit a graphical abstract that visually summarizes their article. Proofreading services will be required for English language quality and a certificate demonstrating this must be presented during the application process. Currently, this certificate is required for articles included in the publication plan.

3. Manuscript Categories

→ Original Article: Full-length presentation of current research related to either basic or clinical knowledge.

Word limit: 6000 words maximum, excluding abstract but including references, tables and figures.
Abstract: 250 words maximum, structured (introduction/aim, material methods, results, discussion).

→ Short Paper: Short papers cover new findings that could substantially and immediately affect research or clinical practice. Short papers do not include case reports.

Word limit: 1800 words maximum, excluding abstract but including tables, figures and references,.
Abstract: 100 words maximum, unstructured (no use of subheadings).
Figures/ tables: Maximum 5.
References: Maximum 30.

Supporting information is not allowed for short papers.

→ Case Report: Clinical cases of exceptional interest and novelty are considered for publication. If appropriate, the Editor may ask authors to rewrite case reports as “Letters to the Editor”.

Word limit: 1200 words maximum, excluding abstract but including references, tables and figure legends.
Abstract: 100 words maximum, unstructured (no use of subheadings).
Figures/ tables: Maximum 2.
References: Maximum 10.

→ Letters to the Editor: Letters may be submitted to the Editor on any topic of discussion: clinical observations, as well as comments on papers published in recent issues. Letters to the Editor are subject to peer review. Letters can use an arbitrary title.

The responses to the letter from authors must cite the title of the letter: e.g. Response to [title of letter]. This ensures that readers can track the line of discussion.

Word limit: 500 words maximum.
Abstract: No abstract.
Figures/ tables: Maximum 1.
References: Maximum 5.

→ Review Article: Survey, evaluation and critical interpretation of recent research, data and concepts in the fields covered by the journal review articles will undergo peer review prior to acceptance.

Word limit: 8000 words maximum, excluding abstract but including tables, figures and references.
Abstract: 250 words maximum, unstructured (no use of subheadings).
Figures/tables: If figures or tables have been reproduced from another source, a letter from the copyright holder (usually the Publisher), stating authorization to reproduce the material, must be attached to the covering letter.

→ Editorial Critical: comments and overview about an article or an updated subject invited by the Editor.

Word Limit: 1500 words maximum.
Abstract: No abstract.
References: Maximum 5.

4. Submission of Manuscript

Manuscripts must be submitted online at: https://www.journalagent.com/jtsm

If there are any problems using the site or managing a manuscript, please contact with Galenos Yayınevi or Editorial Board.

Authors must supply an email address as all correspondence will be by email.

The ORCID ID (Open Researcher and Contributor ID) number of the correspondence author should be provided while sending the manuscript. A free registration can be done at http://orcid.org.

→ General All articles submitted to the Journal should comply with these instructions. Otherwise, the manuscript will be returned to the author and publication may be delayed.

Do not use ‘Enter’ at the end of lines within a paragraph.
Turn the hyphenation option off; includeonly those hyphens that are essential tothe meaning.
Specify any special characters used to rep-resent non-English characters.
Do not use l (ell) for 1 (one), O (capital o) for 0 (zero) or ß (German esszett) for β (Greek beta).
Use of Large Language Models and Generative AI Tools:
“AI tools cannot meet the requirements for authorship as they cannot take responsibility for the submitted work. As non-legal entities, they cannot assert the presence or absence of conflicts of interest nor manage copyright and license agreements. Authors who use AI tools in the writing of a manuscript, production of images or graphical elements of the paper, or in the collection and analysis of data, must be transparent how the AI tool was used and which tool was used. Authors are fully responsible for the content of their manuscript, even those parts produced by an AI tool, and are thus liable for any breach of publication ethics.” COPE Position Statement on Authorship and AI tools. Detailed information about the statement can be accessed at https://publicationethics.org/cope-position-statements/ai-author
After reviewing the COPE statement, the editors of the Journal of Turkish Sleep Medicine have decided that papers should include a statement in a section called “Declaration Regarding the Use of AI and AI-Assisted Technologies” to let readers know if AI or AI-assisted tools were used in the writing process. It's important to remember that all authors are responsible for the content of their work. This declaration does not apply to the use of basic tools for checking grammar, spelling, or references (such as Mendeley, EndNote, Zotero, and others). If there is nothing to declare, there is no need to add a statement.
It is suggested that authors follow this format when preparing their statement:
During the preparation of this work, the author(s) utilized [NAME OF TOOL(S) USED] to [DESCRIPTION OF HOW THE TOOL(S) WERE UTILIZED AND HOW THE VALIDITY OF THE OUTPUTS WAS EVALUATED]. After carefully reviewing and editing the content as necessary, full responsibility for the publication's content is taken by the author(s). This incorporation of AI tool usage primarily impacted [SPECIFY WHICH ASPECTS OF THE STUDY, ARTICLE CONTENTS, DATA, OR SUPPORTING FILES WERE AFFECTED/GENERATED].
Example:
During the preparation of this work, the author(s) utilized OpenAI's ChatGPT to generate summaries of research articles related to the topic. These summaries were evaluated by comparing them to manually written summaries by experts in the field. Upon confirming the accuracy and relevance of the generated summaries, they were integrated into the literature review section of the manuscript. After carefully reviewing and editing the content as necessary, full responsibility for the publication's content is taken by the author(s). This incorporation of AI tool usage primarily impacted the efficiency of literature review process and the comprehensiveness of the gathered research insights.

5. Structure of Manuscript

The length of manuscripts must adhere to the specifications under the section “Manuscript Ca-tegories”. Manuscripts that do not adhere to the following instructions will be returned to the corresponding author for technical revision before undergoing peer review (unsubmitted). Manuscripts should be presented in the following order: Title page, abstract and key words, text, acknowledgments including disclosure, references, figure legends, tables and figures. Footnotes to the text are not allowed and any such material should be incorporated into the text as parenthetical matter.

→ Title Page: The title page should contain:

Manuscript category
The title of the paper
The running title of the paper
The full names of the authors and their institutions
The addresses of the institutions at which the work was carried out together
The full postal and email address, plus facsimile and telephone numbers, of the corresponding author
Word count

The title should be less than 120 characters. Do not use abbreviations in the title, other than common abbreviations such as REM, DNA and so on. A short running title (less than 40 char-acters including spaces) should also be provided.

→ Abstract And Keywords: The abstract must adhere to the specifications in “Manuscript Ca-tegories”. The abstract should not contain abbreviations other than common abbreviations or references. 3 to 7 key words should be supplied below the abstract in the main text. Keywords should be listed in full, without abbreviations. English keywords should align with the 'Medical Subject Headings' (MESH) available at https://www.nlm.nih.gov/. Turkish keywords should be provided in accordance with the Türkiye Bilim Terimleri available at https://www.bilimterimleri.com/.

→ Text: Authors should set out the sections of the manuscript as follows: Introduction, Materi-als and Methods, Results, Discussion, in this order. Please note that the requirements differ ac-cording to manuscript types. Please refer to “Manuscript Categories”.

→ Acknowledgments/ Disclosure: Authors must declare any financial support or relationships that may pose a conflict of interest. The source of financial grants and other funding must be disclosed. Authors may consider, as a guide for financial disclosures, reporting interests as de-scribed in the following list: Employment/leadership position/advisory role, stock ownership, patent royalties/licensing fees, honoraria (e.g. lecture fees), fees for promotional materials (e.g. manuscript fees), research funding, or other (e.g. trips, travel, or gifts which are not related to research).

→ References: Both in-text citations and the references must be prepared according to the AMA Manual of style.

While citing publications, preference should be given to the latest, most up-to-date publications. Authors are responsible for the accuracy of references. If an ahead-of-print publication is cited, the DOI number should be provided. Journal titles should be abbreviated in accordance with the journal abbreviations in Index Medicus/MEDLINE/PubMed. When there are six or fewer authors, all authors should be listed. If there are seven or more authors, the first three authors should be listed followed by “et al.” In the main text of the manuscript, references should be cited in superscript after punctuation. The reference styles for different types of publications are presented in the following examples.

Journal Article: Economopoulos KJ, Brockmeier SF. Rotator cuff tears in overhead athletes. Clin Sports Med. 2012;31(4):675-692.

Book Section: Fikremariam D, Serafini M. Multidisciplinary approach to pain management. In: Vadivelu N, Urman RD, Hines RL, eds. Essentials of Pain Management. New York, NY: Springer New York; 2011:17-28.

Books with a Single Author: Patterson JW. Weedon’s Skin Pahology. 4th ed. Churchill Livingstone; 2016.

Editor(s) as Author: Etzel RA, Balk SJ, eds. Pediatric Environmental Health. American Academy of Pediatrics; 2011.

Conference Proceedings: Morales M, Zhou X. Health practices of immigrant women: indigenous knowledge in an urban environment. Paper presented at: 78th Association for Information Science and Technology Annual Meeting; November 6-10; 2015; St Louis, MO. Accessed March 15, 2016. https://www.asist.org/files/meetings/am15/proceedings/openpage15.html

Thesis: Maiti N. Association Between Behaviours, Health Charactetistics and Injuries Among Adolescents in the United States. Dissertation. Palo Alto University; 2010.

Online Journal Articles: Tamburini S, Shen N, Chih Wu H, Clemente KC. The microbiome in early life: implications for health outcometes. Nat Med. Published online July 7, 2016. doi:10.1038/nm4142

Epub Ahead of Print Articles: Websites: International Society for Infectious Diseases. ProMed-mail. Accessed February 10, 2016. http://www.promedmail.org

→ Figure Legends: Figure legends should be provided separately from the figures. All illustra-tions, including line drawings and photographs, are classified as figures. Figures should be cit-ed in consecutive order in the text. Each figure should be supplied as a separate file, with the figure number incorporated in the file name. For submission, low-resolution figures saved as .jpg or .bmp files are acceptable for ease of transmission during the review process. After ac-ceptance the authors could be asked to provide higher resolution figures for publication.

Size: Figure sizes should fit within a single column (82 mm), an intermediate size (118 mm), or the full text width (173 mm).
Resolution: Figures must be supplied as high resolution .eps or .tif files.
The specifications for the figures are the following: halftone figures 300 dpi (dots per inch); color figures 300 dpi saved as CMYK; figures containing text 400 dpi; line figures 1000 dpi. Figure files should be set up in CMYK (cyan, magenta, yellow, black) mode, not in RGB (red, green, blue) mode.
Line figures: Line figures must be sharp black and white graphs or diagrams, drawn profes-sionally or with a computer graphics package.
Text sizing in figures: Lettering must be included and should be sized to be no larger than the journal text or 8 point. (Text should be readable after reduction - avoid large type or thick lines.)
Line width: Between 0.5 and 1 point. More help on preparation of illustrations can be found here: http://authorservices. wiley.com/bauthor/ author.asp

→ Tables: Each table should be supplied as a separate file with the table number in the file name.

Provide tables on a separate sheet with caption, explanation and the title of the table.

Tables must be supplied as editable text. The tables should be numbered in the text in Arabic numerals.

Vertical lines should not be used. All abbreviations must be defined. Symbols: †, ‡, §, ¶, should be used (in that order) and , *, *** should be reserved for P-values. Statistical measures such as SD or SEM can be used without definition.

→ Equations: Equations should be numbered sequentially with Arabic numerals; these should be ranged right in parentheses. All variables should appear in italics.

Examples:

dx/dt = c(x − x3/3 + y + z) (1)

DY/DT = −(X + BY − A)/C (2)

Supporting Information: Supporting information closely related to the relevant findings is ac-ceptable.

6. Style of Manuscript

→ Spelling: Foreign names and terms, such as names of chemicals, should be written in the original language. Proper nouns and German nouns should be capitalized.

→ Units: All measurements must be given in SI or SIderived units. For more information about SI units, please go to the Bureau International des Poids et Mesures (BIPM) website at: http://www.bipm.fr

→ Abbreviations: Use abbreviations only sparingly. Initially use the word spelt out in full, followed by the abbreviation in parentheses. Common abbreviations such as DNA are excluded.

→ Trade Names: Drugs and chemicals should not be referred to by their trade names. If proprietary drugs or chemicals have been used in the study, refer to them by their generic name, mentioning the proprietary name and the name and location of the manufacturer in parentheses.

The Editorial Policies and General Guidelines for manuscript preparation specified below are based on “Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals (ICMJE Recommendations)” by the International Committee of Medical Journal Editors (ICMJE) (http://www.icmje.org).

Preparation of original articles, systematic reviews, meta-analyses, and case reports must comply with study design guidelines:

CONSORT statement for randomized controlled trials (Moher D, Schultz KF, Altman D, for the CONSORT Group. The CONSORT statement revised recommendations for improving the quality of reports of parallel group randomized trials. JAMA 2001; 285: 1987-91) (http://www.consort-statement.org),
PRISMA statement of preferred reporting items for systematic reviews and meta-analyses (Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 2009; 6(7): e1000097.) (http://www.prisma-statement.org),
STARD checklist for the reporting of studies of diagnostic accuracy (Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al., for the STARD Group. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Ann Intern Med 2003;138:40-4.) (http://www.stard-statement.org),

STROBE statement, a checklist of items that should be included in reports of observational studies (http://www.strobe-statement.org),

MOOSE guidelines for meta-analysis and systemic reviews of observational studies (Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting Meta-analysis of observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-12),
CARE guidelines are designed to increase the accuracy, transparency, and usefulness of case reports. (Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D; the CARE Group. The CARE Guidelines: Consensus-based Clinical Case Reporting Guideline Development.) (http://www.care-statement.org)

7. Proofs

Notification of the URL from which to download a Portable Document Format (PDF) typeset page proof, associated forms and further instructions will be sent by email to the corresponding author. The purpose of the PDF proof is a final check of the layout, and of tables and figures. Alterations other than essential corrections of errors are unacceptable at PDF proof stage.

8. Ethical Considerations

Authors must state that the research project has been approved by an ethics committee of the institution where the work was undertaken. Written consent is not a requirement, but the Editor retains the right to request such documentation. Any experiments involving animals must be approved by an institutional ethical committee which must be declared in the text.

9. Clinical Trials Registry

All clinical trials must be registered. Authors must include registration details in the manuscript. We define a clinical trial as any research project that prospectively assigns human subjects to intervention or comparison groups to study the cause-and-effect relationship between a medical intervention and a health outcome.

10. Copyright

All authors must agree to the conditions outlined in the Exclusive License Form, and must sign the form or agree that the corresponding author may sign on their behalf. In signing the form it is assumed that authors have obtained permission to use any copyrighted or previously published material. Authors can download the form here.

11. Tracking Manuscript

Before acceptance authors can track a manuscript’s progress through the review process at: https://www.journalagent.com/jtsm
After acceptance authors can get information about the production process of their paper by registering at Galenos Yayinevi. This enables authors to track their article, once it has been accepted, through the production process to publication online. Authors can receive automated emails at key stages of production so they do not need to contact the Production Editor to check on progress. For more details on online production tracking and for a wealth of resources, including FAQs and tips on article preparation, submission and more, visit: http://www.tutd.org.tr

12. Early View

An Early View article is a complete full-text article published on line in advance of publication in an issue. The article is therefore available as soon as it is ready. The Early View article is given a Digital Object Identifier (DOI), which allows the article to be cited and tracked before it is allocated to an issue. Before online publication, the DOI remains valid and can continue to be used to cite and access the article. More information about DOIs can be found at: http://www.doi.org/faq.html

13. The Journal Online

Turkish Sleep Medicine Society (TSMS)

Address: Naci Çakır Mah. 760. Sok. Esenkent Sitesi D Apt. No: 25 D: 17 Çankaya, Ankara/Türkiye

Phone: 0530 409 82 60

Fax: 0312 480 89 58

E-mail: dergi@tutd.org.tr